Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 7, 2009

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
GlioblastomaCNS DiseaseBrain Diseases
Interventions
DRUG

Dasatinib

Starting dose of 150 mg/day administered by mouth daily on Days 1 to 28 of every 28 day cycle, beginning on the first day of RT.

RADIATION

RT (Radiotherapy)

As a part of standard of care, receive 60 Gy radiation therapy Monday-Friday for a total of 30 radiation treatments (about 6 weeks).

DRUG

TMZ (Temozolomide)

75 mg/m\^2 capsules daily by mouth for up to a maximum of 7 weeks beginning first day of RT until RT end followed by 4 weeks off then 150 mg/m\^2 daily on Days 1-5 of each 28 day study cycle and 200 mg/m\^2 daily of subsequent cycles.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER